✦ LIBER ✦

In vitro and in vivo availability of commercial prednisone tablets

✍ Scribed by Timothy J. Sullivan; Ermelinda Sakmar; Kenneth S. Albert; Donald C. Blair; John G. Wagner

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 283 KB
Volume: 64
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600641035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo bioequivalence of c

In vitro and in vivo bioequivalence of commerical prednisone tablets

✍ G. E. Francisco; I. L. Honigberg; J. T. Stewart; J. A. Kotzan; W. J. Brown; W. L 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 2 views

Availability of Metoclopramide in vitro

Availability of Metoclopramide in vitro and in vivo

✍ Hartmut Vergin; Konrad Strobel; Jochen Grätzel v. Grätz 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

Peristaltic dissolution apparatus: Predi

Peristaltic dissolution apparatus: Prediction of relative in vivo performance of prednisone tablets in humans

✍ D. L. Simmons; A. A. Legore; P. Picotte 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 1 views

Drug adsorption efficacy of commercial a

Drug adsorption efficacy of commercial activated charcoal tablets in vitro and in man

✍ Tamehiro Tsuchiya; Gerhard Levy 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

Comparison of in vitro dissolution and i

Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans

✍ Roger G. Stoll; George C. Chao; Harvey J. Hoyt; Avraham Yacobi 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 1 views

Bioequivalence study of nalidixic acid t

Bioequivalence study of nalidixic acid tablets: In vitro–in vivo correlation

✍ H. Jung; H. Gonzalez; J. M. Rodriguez 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

The USP dissolution test was used to select seven products with a wide range of dissolution characteristics for in vivo examination. The bioequivalence of seven (500 mg) products was evaluated in two crossover urinary excretion experiments. In each study three products were compared with the innovat